Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 1.00 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 1.00 |
| ▸ | HPGD | P15428 | 2/20 | 1.00 |
| ▸ | MAPT | P10636 | 5/20 | 0.71 |
| ▸ | RAB9A | P51151 | 2/20 | 0.69 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.69 |
| ▸ | LMNA | P02545 | 1/20 | 0.69 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.69 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.69 |
| ▸ | HSD17B3 | P37058 | 1/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.61 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.61 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.60 |
| ▸ | GSK3B | P49841 | 1/20 | 0.60 |
| ▸ | USP2 | O75604 | 1/20 | 0.59 |
| ▸ | ERCC5 | P28715 | 1/20 | 0.56 |
| ▸ | FEN1 | P39748 | 1/20 | 0.56 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.56 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8535123 | 0.89 | SMN1; SMN2 (0.80) | SMN1; SMN2L3MBTL1HPGDMAPTRAB9A | |
| SCHEMBL6606979 | 0.89 | L3MBTL1 (0.79) | SMN1; SMN2L3MBTL1HPGDMAPTRAB9A | |
| Butyrophenone SCHEMBL11522791 | 0.87 | L3MBTL1 (0.77) | SMN1; SMN2L3MBTL1HPGDMAPTRAB9A | |
| Butyrophenone SCHEMBL82532 | 0.87 | L3MBTL1 (0.77) | SMN1; SMN2L3MBTL1HPGDMAPTRAB9A | |
| Butyrophenone SCHEMBL9725428 | 0.87 | L3MBTL1 (0.77) | SMN1; SMN2L3MBTL1HPGDMAPTRAB9A | |
| Butyrophenone SCHEMBL25423577 | 0.87 | L3MBTL1 (0.77) | SMN1; SMN2L3MBTL1HPGDMAPTRAB9A | |
| SCHEMBL4453789 | 0.87 | L3MBTL1 (0.77) | SMN1; SMN2L3MBTL1HPGDMAPTRAB9A | |
| SCHEMBL13670588 | 0.85 | L3MBTL1 (0.74) | SMN1; SMN2L3MBTL1HPGDMAPTRAB9A | |
| SCHEMBL10282853 | 0.85 | L3MBTL1 (0.74) | SMN1; SMN2L3MBTL1HPGDMAPTRAB9A | |
| SCHEMBL9229529 | 0.85 | L3MBTL1 (0.74) | SMN1; SMN2L3MBTL1HPGDMAPTRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120149327-A | Solid composite alkali metal negative electrode, preparation method thereof and secondary battery | 中国科学院苏州纳米技术与纳米仿生研究所 | 2025-06-13 | — | — | CN | claimed |
| WO-2024114056-A1 | COMPOSITE MATERIAL AND PREPARATION METHOD THEREFOR, AND LIGHT-EMITTING DEVICE | 广东聚华新型显示研究院 | 2024-06-06 | — | — | WO | claimed |
| CN-118119253-A | Composite material, preparation method thereof and light-emitting device | 广东聚华新型显示研究院 | 2024-05-31 | — | — | CN | claimed |
| CN-120149327-A | Solid composite alkali metal negative electrode, preparation method thereof and secondary battery | 中国科学院苏州纳米技术与纳米仿生研究所 | 2025-06-13 | — | — | CN | disclosed |
| WO-2025070078-A1 | ACTIVE ENERGY RAY-CURABLE OFFSET PRINTING INK, PRINTED MATTER USING SAME, AND PRINTED MATTER MANUFACTURING METHOD | ＤＩＣグラフィックス株式会社 | 2025-04-03 | — | — | WO | disclosed |
| CN-119118807-A | Method for synthesizing aryl butanone by ligand-regulated nickel-catalyzed aryl cyclopropyl ketone ring-opening hydrogenation | 陕西师范大学 | 2024-12-13 | — | — | CN | disclosed |
| US-12148883-B2 | Lithium secondary battery | PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) | 2024-11-19 | — | — | US | disclosed |
| CN-111727525-B | Lithium secondary battery | 松下知识产权经营株式会社 | 2024-07-02 | — | — | CN | disclosed |
| CN-111684645-B | Lithium secondary battery | 松下知识产权经营株式会社 | 2024-06-07 | — | — | CN | disclosed |
| WO-2024114056-A1 | COMPOSITE MATERIAL AND PREPARATION METHOD THEREFOR, AND LIGHT-EMITTING DEVICE | 广东聚华新型显示研究院 | 2024-06-06 | — | — | WO | disclosed |
| CN-118119253-A | Composite material, preparation method thereof and light-emitting device | 广东聚华新型显示研究院 | 2024-05-31 | — | — | CN | disclosed |
| US-20080241434-A1 | THERMAL TRANSFER INK SHEET, INK CARTRIDGE, COATING COMPOSITION FOR DYE LAYER OF THERMAL TRANSFER INK SHEET, AND THERMAL TRANSFER RECORDING METHOD | FUJIFILM CORPORATION (JP) | 2008-10-02 | — | — | US | disclosed |
| US-20080241434-A1 | THERMAL TRANSFER INK SHEET, INK CARTRIDGE, COATING COMPOSITION FOR DYE LAYER OF THERMAL TRANSFER INK SHEET, AND THERMAL TRANSFER RECORDING METHOD | FUJIFILM CORPORATION (JP) | 2008-10-02 | — | — | US | disclosed |
| EP-1974944-A1 | Thermal transfer ink sheet, ink cartridge, coating composition for dye layer of thermal transfer ink sheet, and thermal transfer recording method | FUJIFILM Corporation (JP) | 2008-10-01 | — | — | EP | disclosed |
| EP-1910359-A1 | PYRIDO [2 , 3-D]PYRIMIDINE-2 , 4-DIAMINE COMPOUNDS AS PTPlB INHIBITORS | F. Hoffmann-Roche AG (CH) | 2008-04-16 | — | — | EP | disclosed |
| US-20070112194-A1 | Process for preparing nitrooxyalkyl substituted esters of carboxylic acids, intermediates useful in said process and preparation thereof | NICOX S.A. (FR) | 2007-05-17 | — | — | US | disclosed |
| WO-2007009911-A1 | PYRIDO [2 , 3-D] PYRIMIDINE-2 , 4-DIAMINE COMPOUNDS AS PTPlB INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 2007-01-25 | — | — | WO | disclosed |
| US-20070021445-A1 | Pyridopyrimidine protein tyrosine phosphatase inhibitors | BERTHEL STEVEN J | 2007-01-25 | — | — | US | disclosed |
| EP-0046413-B1 | RECORDING MEDIUM | Hitachi, Ltd. (JP) | 1985-06-05 | — | — | EP | disclosed |
| US-3992472-A | Synthesis of ethylenically unsaturated compounds from aldehydes or ketones | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1976-11-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070112194-A1 | Process for preparing nitrooxyalkyl substituted esters of carboxylic acids, intermediates useful in said process and preparation thereof | CYP2A13, CYP3A43, POR | SMN1; SMN2 3700/4885L3MBTL1 4798/4885HPGD 1168/4885 |
| US-20070021445-A1 | Pyridopyrimidine protein tyrosine phosphatase inhibitors | PTPRF, PTPN1, PTPRCAP | SMN1; SMN2 3969/4885L3MBTL1 4399/4885HPGD 2194/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.